CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/077CF30B.svg?ark=w1%2F20260515%2F077CF30B&value=id)](https://nobleid.org/work/w1/20260515/077CF30B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors